NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use.

MLA

Skulberg, Arne Kristian, et al. “NTNU Intranasal Naloxone Trial (NINA-1) Study Protocol for a Double-Blind, Double-Dummy, Non-Inferiority Randomised Controlled Trial Comparing Intranasal 1.4 Mg to Intramuscular 0.8 Mg Naloxone for Prehospital Use.” BMJ Open, vol. 10, no. 11, Nov. 2020, p. e041556. EBSCOhost, https://doi.org/10.1136/bmjopen-2020-041556.

APA

Skulberg, A. K., Tylleskär, I., Braarud, A.-C., Dale, J., Heyerdahl, F., Mellesmo, S., Valberg, M., & Dale, O. (2020). NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use. BMJ Open, 10(11), e041556. https://doi.org/10.1136/bmjopen-2020-041556

Chicago

Skulberg, Arne Kristian, Ida Tylleskär, Anne-Cathrine Braarud, Jostein Dale, Fridtjof Heyerdahl, Sindre Mellesmo, Morten Valberg, and Ola Dale. 2020. “NTNU Intranasal Naloxone Trial (NINA-1) Study Protocol for a Double-Blind, Double-Dummy, Non-Inferiority Randomised Controlled Trial Comparing Intranasal 1.4 Mg to Intramuscular 0.8 Mg Naloxone for Prehospital Use.” BMJ Open 10 (11): e041556. doi:10.1136/bmjopen-2020-041556.